PDUFAin 103d
Apnimed, Inc. — Oxnimbi (AD109)
FDA PDUFA goal date for Oxnimbi (aroxybutynin and atomoxetine) oral NDA.
- Date
- Feb 28, 2027
- Type
- PDUFA
- Ticker
- APMD
- Indication
- Obstructive sleep apnea
PDUFAin 103d
FDA PDUFA goal date for Oxnimbi (aroxybutynin and atomoxetine) oral NDA.
The weekly brief is free. Pro adds reminders 7 days and 1 day before.